Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

Saved in:
Bibliographic Details
Published inBlood advances Vol. 7; no. 18; pp. 5603 - 5607
Main Authors Schuelke, Matthew R., Bassiri, Hamid, Behrens, Edward M., Canna, Scott, Croy, Colleen, DiNofia, Amanda, Gollomp, Kandace, Grupp, Stephan, Lambert, Michele, Lambrix, Arathi, Maude, Shannon L., Myers, Regina, Newman, Haley, Petrosa, Whitney, Seif, Alix, Sullivan, Kathleen E., Teachey, David T., Diorio, Caroline
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 26.09.2023
The American Society of Hematology
Subjects
Antibodies, Monoclonal - adverse effects
Antibodies, Neutralizing
Child
Cytokine Release Syndrome - drug therapy
Cytokine Release Syndrome - etiology
Humans
Research Letter
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:2473-9529
2473-9537
DOI:10.1182/bloodadvances.2023010712